10 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Inhibitors of proteases and amide hydrolases that employ an alpha-ketoheterocycle as a key enabling functionality.
Johnson & Johnson Pharmaceutical Research & Development
Structure-activity relationships for substrate-based inhibitors of human complement factor B.
The University of Queensland
Profiling the enzymatic properties and inhibition of human complement factor B.
University of Queensland
Discovery of 4-((2 S,4 S)-4-Ethoxy-1-((5-methoxy-7-methyl-1 H-indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated Diseases
Novartis Institutes For Biomedical Research
Chemical Approaches to Modulating Complement-Mediated Diseases.
The University of Queensland
1 H-pyrazol-1-yl-thiazoles as inhibitors of lactate dehydrogenase and methods of use thereof
The Trustees of The University of Pennsylvania
Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism
University of Michigan
Salicylanilide diethyl phosphates as cholinesterases inhibitors.
Charles University In Prague